Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

47.85 +0.34 (+0.72%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 3, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	683,811
Open	47.51
Bid (Size)	47.50 (200)
Ask (Size)	49.00 (300)
Prev. Close	47.51
Today's Range	47.28 - 48.37
52wk Range	23.23 - 48.37
Shares Outstanding	32,250,236
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

1 Small-Cap Stock with Exciting Potential and 2 We Avoid

November 23, 2025

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small...

Via StockStory

Branded Pharmaceuticals Stocks Q3 Earnings: Eli Lilly (NYSE:LLY) Best of the Bunch

November 17, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Eli Lilly (NYSE:LLY) and the...

Via StockStory

Performance

YTD	+67.1%	+67.1%
1 Month	+32.5%	+32.5%
3 Month	+20.9%	+20.9%
6 Month	+62.8%	+62.8%
1 Year	+56.1%	+56.1%

More News

Collegium Pharmaceutical Inc (NASDAQ:COLL) Shows High Growth Momentum with Strong Technicals ↗

November 13, 2025

Via Chartmill

5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q3 Earnings Call

November 13, 2025

Via StockStory

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off

November 12, 2025

Via StockStory

Collegium to Participate in Upcoming Investor Conferences

November 12, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

2 Momentum Stocks with Exciting Potential and 1 We Find Risky

November 10, 2025

Via StockStory

COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook

November 07, 2025

Via StockStory

Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today

November 06, 2025

Via StockStory

Collegium Pharmaceutical Inc (NASDAQ:COLL) Beats Q3 2025 Estimates and Raises Full-Year Guidance ↗

November 06, 2025

Via Chartmill

Collegium Pharmaceutical (NASDAQ:COLL) Delivers Impressive Q3, Stock Jumps 12.1%

November 06, 2025

Via StockStory

Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance

November 06, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Earnings To Watch: Collegium Pharmaceutical (COLL) Reports Q3 Results Tomorrow

November 04, 2025

Via StockStory

3 Stocks Under $50 That Fall Short

October 31, 2025

Via StockStory

Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment

October 29, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025

October 23, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium Pharmaceutical (COLL): Buy, Sell, or Hold Post Q2 Earnings?

October 23, 2025

Via StockStory

Collegium Announces Poster Presentations at the American Academy of Child & Adolescent Psychiatry and Neuroscience Education Institute Conferences

October 22, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Collegium to Celebrate 10-Year Anniversary with Nasdaq Opening Bell Ringing

October 13, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

UnitedHealth, Brookdale, Collegium Pharmaceutical, QuidelOrtho, and Biogen Shares Are Falling, What You Need To Know

October 10, 2025

Via StockStory

1 Russell 2000 Stock to Research Further and 2 We Avoid

September 26, 2025

Via StockStory

Branded Pharmaceuticals Stocks Q2 Highlights: Collegium Pharmaceutical (NASDAQ:COLL)

September 24, 2025

Via StockStory

1 Safe-and-Steady Stock to Keep an Eye On and 2 Facing Headwinds

September 12, 2025

Via StockStory

Collegium to Participate in Upcoming Investor Conferences

August 28, 2025

From Collegium Pharmaceutical, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?

Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.

What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?

Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?

The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market

What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?

The current price of Collegium Pharmaceutical, Inc. - Common Stock is 47.85

When was Collegium Pharmaceutical, Inc. - Common Stock last traded?

The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 12/03/25 04:00 PM ET

What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?

The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.54B

How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?

Collegium Pharmaceutical, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.